Nuclidium secures $98M in Series B funding

AuntMinnie.com staff writers
Jul 14, 2025

Nuclidium has secured $98 million (84 million euros) in Series B funding.

The company plans to use the funding to advance clinical development of its copper-61 (Cu-61)/copper-67 (Cu-67) theranostic pipeline across multiple oncology indications, it said.

The round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR (Intesa Sanpaolo Group), with participation from DeepTech & Climate Fonds (DTCF), Bayern Kapital, Vives Partners, Eurazeo, NRW.BANK and HighLight Capital, Nuclidium said.

Latest in Molecular Imaging
Research presentation on nuclear medicine fragmentation showing 25 studies with PET imaging criteria analysis and expert interview
EANM: Is ‘research fragmentation’ holding back nuclear medicine?
October 21, 2026
Explore Innovations at EANM 2026
Sponsored
Explore Innovations at EANM 2026
October 1, 2026
GE HealthCare CT scanner with gray housing, purple accent ring, and sliding patient table
GEHC begins global clinical evaluation of StarGuide GX SPECT/CT
October 20, 2026
Comparative PET/CT scan images showing [18F]FAPI and [18F]FDG imaging with MIP projections, fusion views, and CT cross-sections for medical diagnosis
FAPI-PET detects more HCC lesions than FDG-PET
October 20, 2026
Related Stories
Copper chemical element symbol Cu in metallic bronze square design
Radiation Oncology/Therapy
Nuclidium wins patent for Cu-61-based radiodiagnostic program
Prostate Cancer 2
Molecular Imaging
Nuclidium presents phase I results for PSMA tracer at SNMMI
Prostate Cancer 3 D Rendering Social
Nuclear Medicine
Nuclidium begins phase I PSMA clinical trial
Explore Innovations at EANM 2026
Sponsor Content
Explore Innovations at EANM 2026
More in Molecular Imaging
EANM: Is ‘research fragmentation’ holding back nuclear medicine?
By Will Morton
Well-designed studies require collaboration among nuclear medicine, medical oncology, urology, radiation oncology, and clinical trial support.
October 21, 2026
Research presentation on nuclear medicine fragmentation showing 25 studies with PET imaging criteria analysis and expert interview
Telix posts revenue growth in Q3
By AuntMinnie.com staff writers
For the period (end-September 30), Telix had group revenues of $245 million, up from $206 million in the same period last year.
October 21, 2026
Business analyst examining financial data charts and percentages through magnifying glass on laptop screen
GEHC begins global clinical evaluation of StarGuide GX SPECT/CT
By AuntMinnie.com staff writers
Participating sites include health centers in the U.S., Europe, and Asia.
October 20, 2026
GE HealthCare CT scanner with gray housing, purple accent ring, and sliding patient table
FAPI-PET detects more HCC lesions than FDG-PET
By Will Morton
Relative to F-18 FDG, F-18 FAPI-PET/CT produced staging changes in 19 of 32 patients undergoing initial staging, including six true upstagings.
October 20, 2026
Comparative PET/CT scan images showing [18F]FAPI and [18F]FDG imaging with MIP projections, fusion views, and CT cross-sections for medical diagnosis
EANM: Thomas Hope on what’s next in FAP-targeted theranostics
By Will Morton
The innovations and work being done to optimize FAP agents will likely "spill over" to other targets.
October 19, 2026
Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo
Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal
By AuntMinnie.com staff writers
Cu-67 is the therapeutic half of Nuclidium’s theranostic platform, which pairs it with copper-61 (Cu-61) for diagnostic imaging.
October 19, 2026
Hand holding glowing atom symbol with blue and gold light effects against blurred tech background
EANM: Next-generation PET scanner cuts imaging time to one minute
By Will Morton
The scanner's fastest images were rated more highly on average than those from a standard PET/CT scanner.
October 18, 2026
PET scan comparison showing SAFOV baseline and 1-minute and 5-minute time-point imaging with tracer uptake patterns
Capitol Imaging Services acquires Impression Imaging
By AuntMinnie.com staff writers
CIS said the deal is part of its expansion into molecular imaging and theranostics.
October 16, 2026
Two businessmen in suits shaking hands during a professional meeting
IBA gets order for 12 cyclotrons for U.S. PET tracer network
By AuntMinnie.com staff writers
A KIUBE 300 system typically costs between €2.5 million and €5 million.
October 16, 2026
IBA brand logo with white stylized text and circular symbol on green gradient background signage
AtomVie, Jubilant Radiopharma enter distribution partnership
By AuntMinnie.com staff writers
Jubilant will handle receipt, regulatory compliance, and distribution of AtomVie-manufactured radiopharmaceuticals.
October 15, 2026
Digital handshake with blue and orange technology network patterns symbolizing business partnership and innovation
Nusano, Primo Biotechnology ink isotope supply deal
By AuntMinnie.com staff writers
The agreement will support Primo’s cancer therapy pipeline.
October 14, 2026
Glowing atom symbol with blue and orange energy effects over laboratory equipment and scientific instruments
AuntMinnie.com Molecular Imaging Insider
By Will Morton
We’ve highlighted a secondary analysis of the LUNAR trial, with findings suggesting the benefits of lutetium-177 (Lu-177) PNT200 extend to more clinically meaningful disease states.
October 13, 2026
Page 1 of 637
Next Page